Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pignatti, F.
Right arrow Articles by Karim, A. B.M.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pignatti, F.
Right arrow Articles by Karim, A. B.M.F.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 20, Issue 8 (April), 2002: 2076-2084
© 2002 American Society for Clinical Oncology

Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma

By Francesco Pignatti, Martin van den Bent, Desmond Curran, Channa Debruyne, Richard Sylvester, Patrick Therasse, Denes Áfra, Philippe Cornu, Michel Bolla, Charles Vecht, Abul B.M.F. Karim for the European Organization for Research and Treatment of Cancer Brain Tumor Cooperative Group and Radiotherapy Cooperative Group

From the European Organization for Research and Treatment of Cancer Data Center, Brussels, Belgium; University Hospital Rotterdam–Daniel Den Hoed Kliniek, Rotterdam; Westeinde Ziekenhuis, Den Haag; and Vrije Universiteit Hospital, Amsterdam, the Netherlands; National Institute of Neurosurgery, Budapest, Hungary; Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris; and Centre Hospitalier Régional de Grenoble–La Tronche, Grenoble, France.

Address reprint requests to Francesco Pignatti, MD, MSc, European Agency for the Evaluation of Medicinal Products, 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom; email: francesco .pignatti{at}emea.eu.int

PURPOSE: To identify prognostic factors for survival in adult patients with cerebral low-grade glioma (LGG), to derive a prognostic scoring system, and to validate results using an independent data set.

PATIENTS AND METHODS: European Organization for Research and Treatment of Cancer (EORTC) trial 22844 and EORTC trial 22845 are the largest phase III trials ever carried out in adult patients with LGG. The trials were designed to investigate the dosage and timing of postoperative radiotherapy in LGG. Cox analysis was performed on 322 patients from EORTC trial 22844 (construction set), and the results were validated on 288 patients from trial 22845 (validation set). Patients with pilocytic astrocytomas were excluded from this prognostic factor analysis.

RESULTS: Multivariate analysis on the construction set showed that age >= 40 years, astrocytoma histology subtype, largest diameter of the tumor >= 6 cm, tumor crossing the midline, and presence of neurologic deficit before surgery were unfavorable prognostic factors for survival. The total number of unfavorable factors present can be used to determine the prognostic score. Presence of up to two of these factors identifies the low-risk group, whereas a higher score identifies high-risk patients. The validity of the multivariate model and of the scoring system was confirmed in the validation set.

CONCLUSION: In adult patients with LGG, older age, astrocytoma histology, presence of neurologic deficits before surgery, largest tumor diameter, and tumor crossing the midline were important prognostic factors for survival. These factors can be used to identify low-risk and high-risk patients.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
S. Bisdas, M. Kirkpatrick, P. Giglio, C. Welsh, M.V. Spampinato, and Z. Rumboldt
Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for Prime Time in Predicting Short-Term Outcome and Recurrent Disease?
AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 681 - 688.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
R. Liu, K. Solheim, M.-Y. Polley, K. R. Lamborn, M. Page, A. Fedoroff, J. Rabbitt, N. Butowski, M. Prados, and S. M. Chang
Quality of life in low-grade glioma patients receiving temozolomide
Neuro-oncol, January 1, 2009; 11(1): 59 - 68.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
J. Pallud, L. Capelle, L. Taillandier, D. Fontaine, E. Mandonnet, R. Guillevin, L. Bauchet, P. Peruzzi, F. Laigle-Donadey, M. Kujas, et al.
Prognostic significance of imaging contrast enhancement for WHO grade II gliomas
Neuro-oncol, January 1, 2009; 11(2): 176 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
R. Liu, M. Page, K. Solheim, S. Fox, and S. M. Chang
Quality of life in adults with brain tumors: Current knowledge and future directions
Neuro-oncol, January 1, 2009; 11(3): 330 - 339.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. S. Smith, E. F. Chang, K. R. Lamborn, S. M. Chang, M. D. Prados, S. Cha, T. Tihan, S. VandenBerg, M. W. McDermott, and M. S. Berger
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
J. Clin. Oncol., March 10, 2008; 26(8): 1338 - 1345.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
R. Bartha, J.F. Megyesi, and C.J. Watling
Low-Grade Glioma: Correlation of Short Echo Time 1H-MR Spectroscopy with 23Na MR Imaging
AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 464 - 470.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
D. Hagerstrand, A. Smits, A. Eriksson, S. Sigurdardottir, T. Olofsson, M. Hartman, M. Nister, H. Kalimo, and A. Ostman
Gene expression analyses of grade II gliomas and identification of rPTP{beta}/{zeta} as a candidate oligodendroglioma marker
Neuro-oncol, February 1, 2008; 10(1): 2 - 9.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. Schiff, P. D. Brown, and C. Giannini
Outcome in adult low-grade glioma: The impact of prognostic factors and treatment
Neurology, September 25, 2007; 69(13): 1366 - 1373.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
W. Chen
Clinical Applications of PET in Brain Tumors
J. Nucl. Med., September 1, 2007; 48(9): 1468 - 1481.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. T. Wyss, S. Hofer, M. Hefti, E. Bartschi, C. Uhlmann, V. Treyer, and U. Roelcke
Spatial Heterogeneity of Low-Grade Gliomas at the Capillary Level: A PET Study on Tumor Blood Flow and Amino Acid Uptake
J. Nucl. Med., July 1, 2007; 48(7): 1047 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. Mariani, G. Deiana, E. Vassella, A.-R. Fathi, C. Murtin, M. Arnold, I. Vajtai, J. Weis, P. Siegenthaler, M. Schobesberger, et al.
Loss of Heterozygosity 1p36 and 19q13 Is a Prognostic Factor for Overall Survival in Patients With Diffuse WHO Grade 2 Gliomas Treated Without Chemotherapy
J. Clin. Oncol., October 10, 2006; 24(29): 4758 - 4763.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. McCarter, W. Furlong, A. C. Whitton, D. Feeny, S. DePauw, A. R. Willan, and R. D. Barr
Health Status Measurements at Diagnosis As Predictors of Survival Among Adults With Brain Tumors
J. Clin. Oncol., August 1, 2006; 24(22): 3636 - 3643.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J. T. Grier and T. Batchelor
Low-grade gliomas in adults.
Oncologist, June 1, 2006; 11(6): 681 - 693.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
I.-F. Talos, K. H. Zou, L. Ohno-Machado, J. G. Bhagwat, R. Kikinis, P. M. Black, and F. A. Jolesz
Supratentorial Low-Grade Glioma Resectability: Statistical Predictive Analysis Based on Anatomic MR Features and Tumor Characteristics.
Radiology, May 1, 2006; 239(2): 506 - 513.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
S.J. Mills, T.A. Patankar, H.A. Haroon, D. Baleriaux, R. Swindell, and A. Jackson
Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?
AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 853 - 858.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. F. Lang and M. R. Gilbert
Diffusely Infiltrative Low-Grade Gliomas in Adults
J. Clin. Oncol., March 10, 2006; 24(8): 1236 - 1245.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. Stupp, M. E. Hegi, M. J. van den Bent, W. P. Mason, M. Weller, R. O. Mirimanoff, J. G. Cairncross, and on behalf of the European Organisation for Researc
Changing paradigms--an update on the multidisciplinary management of malignant glioma.
Oncologist, February 1, 2006; 11(2): 165 - 180.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Schwartzbaum, F. Jonsson, A. Ahlbom, S. Preston-Martin, B. Malmer, S. Lonn, K. Soderberg, and M. Feychting
Prior Hospitalization for Epilepsy, Diabetes, and Stroke and Subsequent Glioma and Meningioma Risk
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 643 - 650.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
I R Whittle
The dilemma of low grade glioma
J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(suppl_2): ii31 - ii36.
[Full Text] [PDF]

Home page
 NeurologyHome page
C. Lebrun, D. Fontaine, A. Ramaioli, F. Vandenbos, S. Chanalet, M. Lonjon, J. F. Michiels, V. Bourg, P. Paquis, M. Chatel, et al.
Long-term outcome of oligodendrogliomas
Neurology, May 25, 2004; 62(10): 1783 - 1787.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
R. Stupp and B. G. Baumert
Promises and controversies in the management of low-grade glioma
Ann. Onc., December 1, 2003; 14(12): 1695 - 1696.
[Full Text] [PDF]

Home page
 Ann OncolHome page
M. Brada, L. Viviers, C. Abson, F. Hines, J. Britton, S. Ashley, S. Sardell, D. Traish, A. Gonsalves, P. Wilkins, et al.
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas
Ann. Onc., December 1, 2003; 14(12): 1715 - 1721.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
P. D. Brown, J. T. Wald, M. W. McDermott, G. S. Baumann, and T. F. Cloughesy
Oncodiagnosis panel: 2002. Optic nerve glioma or optic nerve meningioma.
RadioGraphics, November 1, 2003; 23(6): 1591 - 1611.
[Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 2002 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online